User profiles for Bingqiu Xiu
 | Bingqiu XiuFudan University Shanghai Cancer Center Verified email at fudan.edu.cn Cited by 528 |
Comparison of prepectoral and subpectoral breast reconstruction after mastectomies: a systematic review and meta analysis
L Li, Y Su, B Xiu, X Huang, W Chi, J Hou… - European Journal of …, 2019 - Elsevier
Background The safety of prepectoral breast reconstruction (PBR) after mastectomies as
compared to subpectoral breast reconstruction (SBR) were unclear, so we conducted a …
compared to subpectoral breast reconstruction (SBR) were unclear, so we conducted a …
[HTML][HTML] LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription
B Xiu, Y Chi, L Liu, W Chi, Q Zhang, J Chen, R Guo… - Molecular cancer, 2019 - Springer
Background The majority of breast cancer patients die of metastasis rather than primary
tumors, whereas the molecular mechanisms orchestrating cancer metastasis remains poorly …
tumors, whereas the molecular mechanisms orchestrating cancer metastasis remains poorly …
[HTML][HTML] A pan-cancer analysis of HER2 index revealed transcriptional pattern for precise selection of HER2-targeted therapy
Background The prevalence of HER2 alterations in pan-cancer indicates a broader range of
application of HER2-targeted therapies; however, biomarkers for such therapies are still …
application of HER2-targeted therapies; however, biomarkers for such therapies are still …
[HTML][HTML] CAPG enhances breast cancer metastasis by competing with PRMT5 to modulate STC-1 transcription
S Huang, Y Chi, Y Qin, Z Wang, B Xiu, Y Su, R Guo… - Theranostics, 2018 - ncbi.nlm.nih.gov
Macrophage-capping protein (CAPG) has been shown to promote cancer cell metastasis,
although the mechanism remains poorly understood. Methods: Breast cancer (BC) tissue …
although the mechanism remains poorly understood. Methods: Breast cancer (BC) tissue …
[HTML][HTML] CapG promotes resistance to paclitaxel in breast cancer through transactivation of PIK3R1/P50
Y Chi, J Xue, S Huang, B Xiu, Y Su, W Wang, R Guo… - Theranostics, 2019 - ncbi.nlm.nih.gov
Background: Chemotherapy resistance is a major problem in breast cancer treatment and a
leading cause of mortality in breast cancer patients. Biomarkers for chemotherapy resistance …
leading cause of mortality in breast cancer patients. Biomarkers for chemotherapy resistance …
[HTML][HTML] The prognoses of young women with breast cancer (≤ 35 years) with different surgical options: a propensity score matching retrospective cohort study
P Li, L Li, B Xiu, L Zhang, B Yang, Y Chi, J Xue… - Frontiers in …, 2022 - frontiersin.org
Background Compared with older patients, young women with breast cancer (YWBCs) have
a poorer prognosis and a higher risk of recurrence. Ages ≤35 years are independent risk …
a poorer prognosis and a higher risk of recurrence. Ages ≤35 years are independent risk …
[HTML][HTML] LINC00478-derived novel cytoplasmic lncRNA LacRNA stabilizes PHB2 and suppresses breast cancer metastasis via repressing MYC targets
R Guo, Y Su, Q Zhang, B Xiu, S Huang, W Chi… - Journal of Translational …, 2023 - Springer
Background Metastasis is the predominant cause of mortality in patients with breast cancer.
Long noncoding RNAs (lncRNAs) have been shown to drive important phenotypes in tumors…
Long noncoding RNAs (lncRNAs) have been shown to drive important phenotypes in tumors…
[HTML][HTML] Immunosuppressive lncRNA LINC00624 promotes tumor progression and therapy resistance through ADAR1 stabilization
Q Zhang, B Xiu, L Zhang, M Chen, W Chi… - … for immunotherapy of …, 2022 - ncbi.nlm.nih.gov
Background Despite the success of HER2-targeted therapy in achieving prolonged survival
in approximately 50% of treated individuals, treatment resistance is still an important …
in approximately 50% of treated individuals, treatment resistance is still an important …
[HTML][HTML] Stabilization of CCDC102B by Loss of RACK1 Through the CMA Pathway Promotes Breast Cancer Metastasis via Activation of the NF-κB Pathway
J Si, R Guo, B Xiu, W Chi, Q Zhang, J Hou, Y Su… - Frontiers in …, 2022 - frontiersin.org
Background Breast cancer is one of the leading causes of cancer-related death among women,
and the pathological status of axillary lymph nodes is an important predictor of prognosis…
and the pathological status of axillary lymph nodes is an important predictor of prognosis…
[HTML][HTML] Cross-talk of four types of RNA modification proteins with adenosine reveals the landscape of multivariate prognostic patterns in breast cancer
X Wang, F Ye, M Xiong, B Xiu, W Chi, Q Zhang… - Frontiers in …, 2022 - frontiersin.org
Background: Breast cancer (BC) is the most common malignant tumour, and its heterogeneity
is one of its major characteristics. N6-methyladenosine (m6A), N1-methyladenosine (m1A)…
is one of its major characteristics. N6-methyladenosine (m6A), N1-methyladenosine (m1A)…
